🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 4 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/05/2021 82,54 85,34 82,50 83,04 +0,50% 3,43% 371.700
06/05/2021 87,17 88,27 81,06 82,63 -8,64% 8,27% 930.100
05/05/2021 90,76 92,48 89,78 90,44 -0,37% 2,97% 371.900
04/05/2021 91,50 91,50 88,70 90,78 -2,25% 3,06% 387.900
03/05/2021 94,24 95,25 92,69 92,87 -1,37% 2,72% 530.000
30/04/2021 94,07 95,66 92,82 94,16 -0,93% 3,02% 382.900
29/04/2021 98,22 98,22 94,11 95,04 -2,72% 4,18% 230.900
28/04/2021 95,99 98,29 95,18 97,70 +1,78% 3,23% 318.600
27/04/2021 96,86 96,86 95,07 95,99 +0,16% 1,85% 298.400
26/04/2021 95,49 96,23 93,09 95,84 +0,89% 3,29% 349.900
23/04/2021 92,19 96,04 92,19 94,99 +3,53% 4,17% 292.500
22/04/2021 91,26 93,10 89,81 91,75 +1,30% 3,61% 260.200
21/04/2021 86,65 90,79 86,65 90,57 +4,61% 4,78% 398.500
20/04/2021 83,28 86,67 83,28 86,58 +3,06% 4,07% 304.700
19/04/2021 84,24 85,74 83,93 84,01 -1,19% 2,15% 401.500
16/04/2021 86,50 86,50 84,82 85,02 -1,02% 1,94% 282.200
15/04/2021 85,40 86,45 84,61 85,90 +1,69% 2,15% 140.300
14/04/2021 83,36 86,00 83,24 84,47 +1,84% 3,31% 267.100
13/04/2021 82,15 84,11 82,15 82,94 +0,53% 2,39% 275.800
12/04/2021 82,79 82,96 80,92 82,50 -0,76% 2,47% 320.200
09/04/2021 85,56 85,81 80,34 83,13 -3,16% 6,39% 386.800
08/04/2021 82,55 85,85 82,44 85,84 +7,37% 4,13% 754.100
07/04/2021 81,85 81,92 79,45 79,95 -2,19% 3,02% 282.000
06/04/2021 80,45 82,99 80,00 81,74 +1,64% 3,72% 541.300
05/04/2021 82,53 82,53 78,87 80,42 -1,89% 4,43% 1.089.600
01/04/2021 84,92 85,18 81,00 81,97 -2,34% 4,92% 720.200
31/03/2021 85,38 86,83 83,63 83,93 -0,65% 3,75% 679.300
30/03/2021 82,57 85,01 81,82 84,48 +1,83% 3,86% 276.600
29/03/2021 84,92 86,98 82,84 82,96 -3,06% 4,88% 291.200
26/03/2021 85,61 86,23 83,01 85,58 +0,68% 3,76% 286.500